Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2024-12-31 00:00:00 ET · period of report 2024-12-30 · accession 0000950170-24-141676 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-31 | 2024-12-30 | BBIO | Satvat Ali J. | Dir | M - OptEx | $16.22 | +159.4K | 159.4K | New | +$2.59M |
| DM | 2024-12-31 | 2024-12-30 | BBIO | Satvat Ali J. | Dir | M - OptEx | $0.00 | -159.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-30 | M | A | 79,702 | $10.99 | 79,702 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-30 | M | A | 39,851 | $16.68 | 119,553 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-30 | M | A | 39,851 | $26.21 | 159,404 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-12-30 | M | D | 79,702 | $0.00 | 0 | D | $10.99 · — to 2028-07-01 | 79,702 Common Stock | (F1) The stock option was fully vested and exercisable on the date of issuance by the Issuer as of January 26, 2021. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-12-30 | M | D | 39,851 | $0.00 | 0 | D | $16.68 · — to 2029-06-12 | 39,851 Common Stock | (F1) The stock option was fully vested and exercisable on the date of issuance by the Issuer as of January 26, 2021. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-12-30 | M | D | 39,851 | $0.00 | 0 | D | $26.21 · — to 2030-05-27 | 39,851 Common Stock | (F1) The stock option was fully vested and exercisable on the date of issuance by the Issuer as of January 26, 2021. |